clonidine has been researched along with prednisone in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blumberg, A; Briner, J; Studer, U | 1 |
| Hadary, A; Haskel, Y; Nissan, S | 1 |
| Arocha, L; Gómez, F; Insausti, CL; Lechin, AE; Lechin, F; Oramas, O; van der Dijs, B; Villa, S | 1 |
| Silverman, MH | 1 |
| Diamond, S; Medina, JL | 1 |
| Bossoni, S; Giustina, A; Licini, M; Macca, C; Milani, G; Wehrenberg, WB | 1 |
| Abdel Fattah, M; Asfour, M; el Zalabany, MM; Madina, EH; Morsi, MR; Soliman, AT | 1 |
| Louie, J; Oftadeh, LC; Oh, C; Song, CH; Yu, KT | 1 |
| Le, C; Nguyen, H | 1 |
1 review(s) available for clonidine and prednisone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for clonidine and prednisone
| Article | Year |
|---|---|
Treatment of ulcerative colitis with clonidine.
Topics: Adolescent; Adult; Clinical Trials as Topic; Clonidine; Colitis, Ulcerative; Endoscopy; Female; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Prednisone; Radiography; Random Allocation; Sulfasalazine | 1985 |
Effect of the combined administration of galanin and clonidine on serum growth hormone levels in normal subjects and in patients under chronic glucocorticoid treatment.
Topics: Adult; Clonidine; Drug Therapy, Combination; Female; Galanin; Humans; Male; Middle Aged; Peptides; Prednisone; Rheumatic Diseases; Somatostatin | 1994 |
18 other study(ies) available for clonidine and prednisone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Hemolytic-uremic syndrome in a young woman following the use of ovulation inhibitors].
Topics: Adult; Blindness; Clonidine; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Diazoxide; Female; Hemolytic-Uremic Syndrome; Humans; Hypertension, Malignant; Kidney; Peritoneal Dialysis; Prednisone; Propranolol; Renin | 1975 |
Pancreatic abscess complicating periarteritis nodosa.
Topics: Adult; Amylases; Clonidine; Cyclophosphamide; Humans; Male; Pancreatic Cyst; Pancreatic Pseudocyst; Polyarteritis Nodosa; Prednisone | 1986 |
Polyarteritis nodosa associated with ulcerative colitis.
Topics: Adolescent; Clonidine; Colectomy; Colitis, Ulcerative; Cyclophosphamide; Humans; Hypertension; Ileostomy; Male; Metoprolol; Minoxidil; Polyarteritis Nodosa; Prednisone | 1984 |
Newer drug therapies for headache.
Topics: Antidepressive Agents; Aspirin; Bromocriptine; Clonidine; Cluster Headache; Dipyridamole; Headache; Humans; Indomethacin; Lithium; Migraine Disorders; Pizotyline; Prednisone; Propranolol | 1980 |
Nocturnal growth hormone (GH) secretion and GH response to clonidine provocation in children before and after long-term prednisone therapy.
Topics: Adrenergic alpha-Agonists; Child; Child, Preschool; Circadian Rhythm; Clonidine; Egypt; Female; Glucocorticoids; Growth Disorders; Growth Hormone; Humans; Male; Nephrotic Syndrome; Prednisone | 1995 |
Successful treatment of steroid-resistant chorea associated with lupus by use of valproic acid and clonidine-HCL patch.
Topics: Administration, Oral; Adolescent; Chorea; Clonidine; Female; Humans; Injections, Intravenous; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Prednisone; Valproic Acid | 1997 |
Cervical myelopathy from spinal sarcoidosis as the unexpected initial presentation for systemic sarcoidosis.
Topics: Adult; Cervical Vertebrae; Clonidine; Contrast Media; Gadolinium DTPA; Glucocorticoids; Humans; Hypesthesia; Magnetic Resonance Imaging; Male; Muscle Relaxants, Central; Muscle Spasticity; Muscle Weakness; Prednisone; Sarcoidosis; Spinal Cord Diseases | 2010 |